Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 6 Pancreatic Neoplasms 4 Neoplasms 3 Colorectal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Prostatic Neoplasms 2 Ovarian Neoplasms 2 Melanoma 2 Lung Neoplasms 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Thymus Neoplasms 1 Thymoma 1 Testicular Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor 1 Sarcoma 1 Rectal Neoplasms 1 Pancreatitis 1 Pancreatic Diseases 1 Neoplasms, Germ Cell and Embryonal 1 Mesothelioma 1 Medulloblastoma 1 Kidney Neoplasms 1 Head and Neck Neoplasms 1 Glioma 1 Esophageal Neoplasms 1 Epilepsy 1 Ependymoma 1

Interventions

Cyclophosphamide 7 pembrolizumab 6 Radiotherapy 6 Cisplatin 6 Sunitinib 5 Carboplatin 5 Paclitaxel 4 Thymectomy 3 130-nm albumin-bound paclitaxel 3 selinexor 2 lenvatinib 2 fludarabine 2 Taxes 2 Robotic Surgical Procedures 2 Ramucirumab 2 Prednisone 2 Pemetrexed 2 Octreotide 2 Nivolumab 2 N,1,4,4-tetramethyl-8-((4-(4-methylpiperazin-1-yl)phenyl)amino)-4,5-dihydro-1H-pyrazolo(4,3-h)quinazoline-3-carboxamide 2 Methylprednisolone 2 Imatinib Mesylate 2 Etoposide 2 Erlotinib Hydrochloride 2 Drug Therapy 2 Doxorubicin 2 Chemoradiotherapy 2 Celecoxib 2 zimberelimab 1 vorolanib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Thymoma × Histocompatibility Testing × Clear all

NCT04162691 2023-01-13

Single Cell Sequencing Analysis of Thymoma

Zhejiang Cancer Hospital

Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡